Occurrence of subacute cutaneous lupus erythematosus after treatment with systemic fluorouracil

Journal of Clinical Oncology

Volumn 29, Issue 20, 2011, Pages

  Almagro, Blanca Moyano ^a   Steyls, Marisol Contreras ^a   Navarro, Norberto López ^a   Domínguez, Elena Gallego ^a   Acosta, Enrique Herrera ^a   Pérez, Maria Angustias Gallardo ^a   Ceballos, Enrique Herrera ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; DEXAMETHASONE; FLUOROURACIL; FOLINIC ACID; GRANISETRON; IMMUNOGLOBULIN M; OXALIPLATIN; RALTITREXED; STEROID;

ADULT; ANGINA PECTORIS; ARTICLE; CASE REPORT; COLORECTAL CANCER; CONTINUOUS INFUSION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; ERYTHEMATOSQUAMOUS SKIN DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PUNCH BIOPSY; SIDE EFFECT; SINUS TACHYCARDIA; SKIN LUPUS ERYTHEMATOSUS; SKIN MANIFESTATION;

ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HEART DISEASES; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MIDDLE AGED;

EID: 79960244551     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.35.0686     Document Type: Article

References (13)

1. Vasoo S: Drug-induced lupus: An update. Lupus 15:757-761, 2006
2. Antonov D, Kazandjieva J, Etugov D, et al: Drug-induced lupus erythematosus. Clin Dermatol 22:157-166, 2004 (Pubitemid 38834266)
3. Takiuchi H, Ajani AJ: Uracil-tegafur in gastric carcinoma: A comprehensive review. J Clin Oncol 16:2877-2885, 1998 (Pubitemid 28363055)
4. Milano G, Ferrero JM, François E: Comparative pharmacology of oral fluoropyrimidines: A focus on pharmacokinetics, pharmacodynamics and pharmacomodulation. Br J Cancer 91:613-617, 2004 (Pubitemid 39141612)
5. Lewis KG, Lewis MD, Robinson-Bostom L, et al: Inflammation of actinic keratoses during capecitabine therapy. Arch Dermatol 140:367-368, 2004 (Pubitemid 38332497)
6. Kluger N, Bessis D, Guillot B: Chronic cutaneous lupus flare induced by systemic 5-fluorouracil. J Dermatolog Treat 17:51-53, 2006 (Pubitemid 43247309)
7. Moazzam N, Malik AA, Mehdi SA, et al: Treatment side effects: Fluorouracil-induced exacerbation of systemic lupus erythematosus J Clin Oncol 20:3032-3034, 2002
8. Weger W, Kränke B, Gerger A, et al: Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine. J Am Acad Dermatol 59:S4-S6, 2008 (suppl 1) (Pubitemid 351952412)
9. Fernandes NF, Rosenbach M, Elenitsas R, et al: Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy. Arch Dermatol 145:340-341, 2009
10. Floristan U, Feltes RA, Sendagorta E, et al: Subacute cutaneous lupus erythematosus induced by capecitabine. Clin Exp Dermatol 34:328-329, 2009
11. Yoshimasu T, Nishide T, Seo N, et al: Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: A novel model for drug-induced cutaneous lupus erythematosus. Clin Exp Immunol 136:245-254, 2004 (Pubitemid 38543442)
12. Adachi A, Nagai H, Horikawa T: Anti-SSA/Ro antibody as a risk factor for fluorouracil-induced drug eruptions showing acral erythema and discoid-lupus-erythematosus-like lesions. Dermatology 214:85-88, 2007 (Pubitemid 46033007)
13. Callen JP: Newly recognized cutaneous drug eruptions. Dermatol Clin 25:255-261, 2007